Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ingiridur Skirnisdottir
Napsin a as a Marker of Clear Cell Ovarian Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
Clinical Significance of Growth Factor Receptor EGFR and Angiogenesis Regulator VEGF‑R2 in Patients With Ovarian Cancer at FIGO Stages�I-Ii
International Journal of Oncology
Cancer Research
Oncology
Related publications
Napsin a Is a Specific Marker for Ovarian Clear Cell Adenocarcinoma
Modern Pathology
Forensic Medicine
Pathology
Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas
Iranian Journal of Pathology
Forensic Medicine
Pathology
Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
Frontiers in Oncology
Cancer Research
Oncology
Cystatin B as a Potential Diagnostic Biomarker in Ovarian Clear Cell Carcinoma
International Journal of Oncology
Cancer Research
Oncology
Potential Targets for Ovarian Clear Cell Carcinoma: A Review of Updates and Future Perspectives
Cancer Cell International
Cancer Research
Oncology
Genetics
DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Validation of 34betaE12 Immunoexpression in Clear Cell Papillary Renal Cell Carcinoma as a Sensitive Biomarker
Pathology
Forensic Medicine
Pathology
Cell-Free 59 kDa Immunoreactive Integrin-Linked Kinase: A Novel Marker for Ovarian Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
MicroRNA-21 Is a Candidate Driver Gene for 17q23-25 Amplification in Ovarian Clear Cell Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics